• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院感染的成本:实验室、抗生素及每日费用在严重金黄色葡萄球菌感染中的相对贡献

Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections.

作者信息

Wakefield D S, Helms C M, Massanari R M, Mori M, Pfaller M

机构信息

Department of Hospital and Health Administration, University of Iowa College of Medicine.

出版信息

Am J Infect Control. 1988 Oct;16(5):185-92. doi: 10.1016/0196-6553(88)90058-2.

DOI:10.1016/0196-6553(88)90058-2
PMID:3264121
Abstract

This study reports an analysis of the relative importance of laboratory antibiotic, and per diem costs of caring for 58 patients with serious Staphylococcus aureus nosocomial infections. Laboratory costs accounted for 2%, antibiotics for 21%, and per diem costs for 77% of total infection-related costs. Only 45% of patients were hospitalized for additional days specifically because of infection, but these patients stayed an average of 18 extra days. Nosocomial infections with S. aureus resistant to penicillinase-resistant penicillins (PRP) were more frequently associated with additional infection-related days of hospitalization than were PRP-susceptible infections. The cost of PRP-resistant infections was also significantly greater than PRP-susceptible infections, primarily because of the costs of additional days of hospitalization. Rational strategies to control costs of nosocomial infection should focus on two approaches: (1) prevention and (2) reduction of acute hospital days attributable to infections.

摘要

本研究报告了对58例严重金黄色葡萄球菌医院感染患者的实验室检查、抗生素使用及每日护理费用的相对重要性分析。实验室检查费用占总感染相关费用的2%,抗生素费用占21%,每日护理费用占77%。仅45%的患者因感染而额外住院,但这些患者平均多住了18天。耐青霉素酶青霉素(PRP)的金黄色葡萄球菌医院感染比PRP敏感感染更常与额外的感染相关住院天数有关。PRP耐药感染的费用也显著高于PRP敏感感染,主要是由于额外住院天数的费用。控制医院感染费用的合理策略应集中在两种方法上:(1)预防和(2)减少因感染导致的急性住院天数。

相似文献

1
Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections.医院感染的成本:实验室、抗生素及每日费用在严重金黄色葡萄球菌感染中的相对贡献
Am J Infect Control. 1988 Oct;16(5):185-92. doi: 10.1016/0196-6553(88)90058-2.
2
Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌引起的医院感染:与抗生素使用及成本驱动因素的关系
Ann Pharmacother. 2008 Mar;42(3):317-26. doi: 10.1345/aph.1K501. Epub 2008 Feb 19.
3
Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?耐甲氧西林金黄色葡萄球菌医院血流感染患者与甲氧西林敏感金黄色葡萄球菌血流感染患者之间的住院费用有差异吗?
Infect Control Hosp Epidemiol. 2009 May;30(5):453-60. doi: 10.1086/596731.
4
Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?医院获得性耐甲氧西林和甲氧西林敏感金黄色葡萄球菌原发性菌血症:代价几何?
Infect Control Hosp Epidemiol. 1999 Jun;20(6):408-11. doi: 10.1086/501641.
5
The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.耐甲氧西林金黄色葡萄球菌在加拿大医院造成的经济影响。
Infect Control Hosp Epidemiol. 2001 Feb;22(2):99-104. doi: 10.1086/501871.
6
[Impact on morbidity and costs of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in intensive care patients].[耐甲氧西林金黄色葡萄球菌医院获得性肺炎对重症监护患者发病率及费用的影响]
Presse Med. 2009 Jan;38(1):25-33. doi: 10.1016/j.lpm.2008.06.005. Epub 2008 Sep 3.
7
Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections.使用适宜性评估方案来估算与医院感染相关的增量成本。
Med Care. 1987 Jun;25(6):481-8. doi: 10.1097/00005650-198706000-00003.
8
Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs.瑞士大学医院耐甲氧西林金黄色葡萄球菌感染负担:住院时间延长和费用增加。
J Hosp Infect. 2013 Jun;84(2):132-7. doi: 10.1016/j.jhin.2013.02.015. Epub 2013 Apr 19.
9
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.2010年和2011年欧洲医院中由对抗菌药物敏感和不敏感的肠杆菌科细菌及金黄色葡萄球菌引起的血流感染的健康和经济负担:一项多中心回顾性队列研究
Euro Surveill. 2016 Aug 18;21(33). doi: 10.2807/1560-7917.ES.2016.21.33.30319.
10
Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.荷兰一家大学医院中耐甲氧西林金黄色葡萄球菌筛查与清除策略的成本
J Hosp Infect. 2008 Apr;68(4):301-7. doi: 10.1016/j.jhin.2008.01.018. Epub 2008 Mar 19.

引用本文的文献

1
Burden of nosocomial infections in intensive care units: Cost of antibiotics, the extra length of stay and mortality rate.重症监护病房医院感染的负担:抗生素成本、额外住院时间和死亡率。
Caspian J Intern Med. 2024 Summer;15(3):478-483. doi: 10.22088/cjim.15.3.478.
2
Antibiotic Treatment in End Stage Cancer Patients; Advantages and Disadvantages.晚期癌症患者的抗生素治疗:利弊
Cancer Inform. 2023 Mar 29;22:11769351231161476. doi: 10.1177/11769351231161476. eCollection 2023.
3
Reducing Hospital-acquired Infection Rate using the Six Sigma DMAIC Approach.
采用六西格玛DMAIC方法降低医院获得性感染率
Saudi J Med Med Sci. 2017 Sep-Dec;5(3):260-266. doi: 10.4103/sjmms.sjmms_98_16. Epub 2017 Aug 21.
4
Costs of hospital-acquired infection and transferability of the estimates: a systematic review.医院获得性感染的成本和估算的可转移性:系统评价。
Infection. 2011 Jun;39(3):185-99. doi: 10.1007/s15010-011-0095-7. Epub 2011 Mar 22.
5
The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.耐甲氧西林金黄色葡萄球菌感染与定植的管理:一份加拿大感染病学会/加拿大抗菌药物管理协会立场文件
Can J Infect Dis. 2004 Jan;15(1):39-48. doi: 10.1155/2004/531434.
6
[Methicillin-resistant Staphylococcus aureus. Types of resistance and clinical consequences].[耐甲氧西林金黄色葡萄球菌。耐药类型及临床后果]
Anaesthesist. 2005 Feb;54(2):155-62. doi: 10.1007/s00101-004-0798-6.
7
Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.将感染成本作为一种工具来证明预防性抗生素疗效的差异:头孢曲松和头孢噻肟预防腹部手术的药物经济学效果的前瞻性随机比较。
World J Surg. 2005 Jan;29(1):18-24. doi: 10.1007/s00268-004-7257-z.
8
Economic impact of Candida colonization and Candida infection in the critically ill patient.念珠菌定植和念珠菌感染对危重症患者的经济影响。
Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):323-30. doi: 10.1007/s10096-004-1104-x. Epub 2004 Mar 13.
9
The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance.加拿大医院耐甲氧西林金黄色葡萄球菌的演变:5年全国监测
CMAJ. 2001 Jul 10;165(1):21-6.
10
Methicillin-Resistant Staphylococcus aureus Infections.耐甲氧西林金黄色葡萄球菌感染
Curr Infect Dis Rep. 1999 Oct;1(4):328-333. doi: 10.1007/s11908-999-0038-y.